The use of angiotensin-converting enzyme (ACE) inhibitors has shown conflicting results in patients with Fontan (17, 18); beta-blocking agents might be helpful to reduce the sympathetic hyperactivity responsible for myocardial hypertrophy, but may also increase the risk of cardiac sinus block. Here, ACE is linked to cardiac hypertrophy.